Laffan RJ[au] - Search Results

Year	Number of Results
1957	3
1961	1
1963	1
1965	1
1972	1
1973	1
1975	1
1976	2
1978	4
1979	2
2022	0

1

Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.

Lee RJ, Evans DB, Baky SH, Laffan RJ. Lee RJ, et al. Among authors: laffan rj. Eur J Pharmacol. 1975 Sep-Oct;33(2):371-82. doi: 10.1016/0014-2999(75)90182-x. Eur J Pharmacol. 1975. PMID: 241655

2

SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.

Rubin B, Laffan RJ, Kotler DG, O'Keefe EH, Demaio DA, Goldberg ME. Rubin B, et al. Among authors: laffan rj. J Pharmacol Exp Ther. 1978 Feb;204(2):271-80. J Pharmacol Exp Ther. 1978. PMID: 202692 No abstract available.

3

Emetic action of nicotine and lobeline.

LAFFAN RJ, BORISON HL. LAFFAN RJ, et al. J Pharmacol Exp Ther. 1957 Dec;121(4):468-76. J Pharmacol Exp Ther. 1957. PMID: 13492162 No abstract available.

4

Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

Laffan RJ, Goldberg ME, High JP, Schaeffer TR, Waugh MH, Rubin B. Laffan RJ, et al. J Pharmacol Exp Ther. 1978 Feb;204(2):281-8. J Pharmacol Exp Ther. 1978. PMID: 202693

5

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.

Rubin B, Antonaccio MJ, Goldberg ME, Harris DN, Itkin AG, Horovitz ZP, Panasevich RE, Laffan RJ. Rubin B, et al. Among authors: laffan rj. Eur J Pharmacol. 1978 Oct 15;51(4):377-88. doi: 10.1016/0014-2999(78)90429-6. Eur J Pharmacol. 1978. PMID: 213296

6

Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.

Antonaccio MJ, Rubin B, Horovitz ZP, Laffan RJ, Goldberg ME, High JP, Harris DN, Zaidi I. Antonaccio MJ, et al. Among authors: laffan rj. Jpn J Pharmacol. 1979 Apr;29(2):285-94. doi: 10.1254/jjp.29.285. Jpn J Pharmacol. 1979. PMID: 231700 Free article.

7

Antiemetic action of fluphenazine (Prolixin): a comparison with other phenothiazines.

LAFFAN RJ, PAPANDRIANOS DP, BURKE JC, CR AVER BN. LAFFAN RJ, et al. J Pharmacol Exp Ther. 1961 Jan;131:130-4. J Pharmacol Exp Ther. 1961. PMID: 13758172 No abstract available.

8

Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.

Harris DN, Heran CL, Goldenberg HJ, High JP, Laffan RJ, Rubin B, Antonaccio MJ, Goldberg ME. Harris DN, et al. Among authors: laffan rj. Eur J Pharmacol. 1978 Oct 15;51(4):345-9. doi: 10.1016/0014-2999(78)90426-0. Eur J Pharmacol. 1978. PMID: 213295

9

Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.

Evans DB, Peschka MT, Lee RJ, Laffan RJ. Evans DB, et al. Among authors: laffan rj. Eur J Pharmacol. 1976 Jan;35(1):17-27. doi: 10.1016/0014-2999(76)90296-x. Eur J Pharmacol. 1976. PMID: 3420

10

Determinants of flexor and extensor components of maximal seizures in cats.

ESPLIN DW, LAFFAN RJ. ESPLIN DW, et al. Among authors: laffan rj. Arch Int Pharmacodyn Ther. 1957 Dec 1;113(1-2):189-202. Arch Int Pharmacodyn Ther. 1957. PMID: 13509784 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results